Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FGXNC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,799
Award facts
- Contract value 100% obligated
- $1,798.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pen injections with a ceiling value of $1,798.95. The contract is a firm fixed price delivery order with no set-aside designation, executed on August 14, 2025, with an ultimate completion date of August 15, 2025. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement. The company's DLA contract portfolio encompasses a broad range of pharmaceutical products and medical supplies supporting Defense Health Agency operations and other government healthcare systems globally. Zepbound, a diabetes medication, represents the type of specialty pharmaceutical commodity that AmerisourceBergen routinely supplies under its IDC framework. The competitively awarded prime contract positions the company to fulfill flexible medical supply requirements across multiple therapeutic domains for the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DB25FGXNC?
SPE2DB25FGXNC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FGXNC worth?
The government has obligated $1,799 on SPE2DB25FGXNC.
Is contract SPE2DB25FGXNC an order under another contract?
Yes. SPE2DB25FGXNC is a delivery order under SPE2DB24D2213, an indefinite delivery contract.
Was contract SPE2DB25FGXNC competed?
The extent of competition for SPE2DB25FGXNC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award